Fully Automated High-Throughput Sorting System Saves Time and Improves High-Throughput Screening
The sorter comprises three linear axes (x, y, and z axes) for moving the sucking tips and the two cameras, the overview camera (C1) and the camera for detailed inspection (C2), above the illuminating LED panel. Credit: https://doi.org/10.1177/2472630317745780
Breitwieser and colleagues of the Karlsruhe Institute of Technology (Germany) describe a fully automated high-throughput sorting system for zebrafish embryo phenotypes that benefits high-throughput screening by saving time and improving accuracy.
The new sorting system is based on a modular robot and an image analysis system comprising two cameras with different magnification lenses and fields of view.
One camera is used to detect clustered objects and isolated embryos, whereas the second camera is used for identifying phenotypes by means of computer-based image analysis. Subsequently, the embryos are transferred by the robot from a Petri dish into the wells of a 96-well microplate. Zebrafish embryo mutants that exhibit a glucocorticoid deficiency are detected reliably and separated from wild type embryos, and the system can easily be extended to sort phenotypes with other morphological features.
Large numbers of genetically modified embryos are needed in research for toxicology testing, drug screening, developmental biology studies and cancer research. Manual sorting of larger numbers of embryos under the microscope is a tedious task and prone to errors.
This article has been republished from materials provided by SLAS. Note: material may have been edited for length and content. For further information, please contact the cited source.
First-in-Human Trial Evaluating Ebola Treatment BeginsNews
A first-in-human trial evaluating an experimental treatment for Ebola virus disease has begun. The Phase 1 clinical trial is examining the safety and tolerability of a single monoclonal antibody called mAb114READ MORE
Avacta Group plc announces successful outcome of “Gene Delivery” collaboration with FIT BiotechNews
Sustained production of Affimer drugs by muscle tissue in vivo could lead to major patient and commercial benefits.READ MORE